Vimarsana
Biggest News Aggregation in the World

Licensed Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Licensed Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Licensed Technologies Today - Breaking & Trending Today

Cielo Announces Fiscal Q3 2024 Financial Results and Provides Update on its Progress to Fuel Renewable Change - Vimarsana News

Cielo Announces Fiscal Q3 2024 Financial Results and Provides Update on its Progress to Fuel Renewable Change

CALGARY, Alberta, March 28, 2024 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV:CMC; OTC:CWSFF) (

NIO Entered Into Technology License Agreement with Forseven Limited - Vimarsana News

NIO Entered Into Technology License Agreement with Forseven Limited

SHANGHAI, China, - NIO Inc. , a pioneer and a leading company in the premium smart electric vehicle market, today announced that its subsidiary, NIO Technology Co., Ltd. , has entered into a...

Cielo Announces Closing of Asset Purchase Transaction with Expander Energy Inc. and Results of Shareholder Meeting - Vimarsana News

Cielo Announces Closing of Asset Purchase Transaction with Expander Energy Inc. and Results of Shareholder Meeting

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.CALGARY, Alberta, Nov. ...

DiaSorin unveils new corporate "Identity" during new website launch - Vimarsana News

DiaSorin unveils new corporate "Identity" during new website launch

DiaSorin Spa on Tuesday unveiled its new corporate Identity during the launch of its new group website: www.diasorin.com Diasorin's new corporate identity is intended to express the group's long...

DiaSorin 2021 Revenues Rise 41 Percent on SARS-CoV-2, Luminex Sales Growth - Vimarsana News

DiaSorin 2021 Revenues Rise 41 Percent on SARS-CoV-2, Luminex Sales Growth

Luminex contributed €195.0 million to DiaSorin's revenues in 2021 and saw strong performance from its Aries and Verigene molecular diagnostic platforms.

Source: 360dx.com